Author of

• 28316

  +

  12 - Debate #2 Neoadjuvant/Adjuvant CT+IO Is Most Likely to Cure the Most Patients (ID 12)

  • Event: TTLC 2019
  • Type: General Session
  • Track:
  • Presentations: 1
  • Moderators:Wolf Lindwasser
  • Coordinates: 2/22/2019, 09:05 - 09:20, Starlight Ballroom

  • 28441

    +

    Adjuvant Is Best (ID 12.02)

    09:05 - 09:20  |  Author(s): Martin Edelman
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.